Page last updated: 2024-08-22

molybdenum and Aprosodia

molybdenum has been researched along with Aprosodia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Askari, F; Brewer, GJ; Carlson, M; Dick, RB; Fink, JK; Hedera, P; Kluin, KJ; Lorincz, MT; Moretti, P; Schilsky, M; Sitterly, J; Tankanow, R	1

Trials

1 trial(s) available for molybdenum and Aprosodia

Article	Year
Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Archives of neurology, 2006, Volume: 63, Issue:4 Topics: Adolescent; Adult; Anemia; Chelating Agents; Copper; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hepatolenticular Degeneration; Humans; Length of Stay; Male; Middle Aged; Molybdenum; Serum Albumin; Speech; Speech Disorders; Treatment Outcome; Trientine; Zinc	2006

Article

Year

Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.

Archives of neurology, 2006, Volume: 63, Issue:4

Topics: Adolescent; Adult; Anemia; Chelating Agents; Copper; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hepatolenticular Degeneration; Humans; Length of Stay; Male; Middle Aged; Molybdenum; Serum Albumin; Speech; Speech Disorders; Treatment Outcome; Trientine; Zinc

2006